AT1 — ATOMO DIAGNOSTICS LIMITED
Data coverage, completeness and provenance for ATOMO DIAGNOSTICS LIMITED in the Stock Market API — Health Care · Medical Devices.
Stored price coverage
Source date: 2026-11-19T05:10:03. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-11-19 | 0.0120 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-11-18 | 0.0130 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-11-17 | 0.0130 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-11-16 | 0.0125 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-11-13 | 0.0120 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/AT1/prices · Price parameters and adjustment semantics
Profile
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-testing programs; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.
Website: https://atomodiagnostics.com · Profile fields populated: 50%
Data completeness by statement
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/AT1/financials.
Financial statement coverage (AUD)
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 28 | yfinance | ||||
| FY2025 (AUD) | 2025-06-30 | 31 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 30 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 30 | yfinance |
Get AT1 data via the API
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Company profile
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/AT1
Financial statements
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/AT1/financials
Computed ratios
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/AT1/metrics/summary
Filings archive
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/AT1/filings
News & announcements
Dated press releases and announcements with source links.
GET /api/v1/companies/AT1/news
Quick start
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/AT1
Query AT1 programmatically
Free tier — instant API key. Built for AI agents.
Other ASX · Health Care companies covered
Frequently Asked Questions
- What data does the API provide for AT1?
- Stored coverage for AT1: price data available, financial statements available, 2 archived filings. REST endpoints are under /api/v1/companies/AT1; inspect available source metadata for provenance.
- How complete is AT1's financial data?
- The anchor reporting period (FY2026) has 82.4% of the 17 core statement fields populated. Primary source: yfinance.
- What reporting periods are covered for AT1?
- 4 fiscal-year periods are stored (FY2023–FY2026), with per-period field counts and source tags available via /api/v1/companies/AT1/financials.
- Where does AT1's data come from?
- Stored price source: yfinance. Primary source for the statement snapshot: yfinance. Inspect available period and field source tags at /api/v1/companies/AT1/financials; missing tags do not establish provenance.